Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ EVA1 Monoclonal Antibody (G9P3-1), PE, eBioscience™

Mouse Monoclonal Antibody

$467.00

Specifications

Antigen EVA1
Clone G9P3-1
Concentration 0.2 mg/mL
Content And Storage 4°C, store in dark, DO NOT FREEZE!
Applications Flow Cytometry
View More Specs

Products 1
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
12-974-282
Encompass_Preferred
View Documents Promotion Details
Invitrogen™
12974282
100 μg
Each of 1 for $467.00
Only null left
Add to Cart
 
Description

Description

Description: The monoclonal antibody G9P3-1 reacts with human and mouse epithelial V-like antigen 1 (EVA1), also known as myelin protein zero-like 2 (MPZL2). EVA1 is a low affinity adhesion type I transmembrane glycoprotein that bears an immunolobulin V-type domain. This glycoprotein is expressed on some epithelial tissues and also on immature thymocytes in the DN3 stage. The DN3 thymocytes are characterized by CD4 and CD8 double negative cells that are CD25 positive and CD44 negative. EVA1 has a role in immature thymocyte development, and thymic regeneration. Applications Reported: This G9P3-1 antibody has been reported for use in flow cytometric analysis. Applications Tested: This G9P3-1 antibody has been tested by flow cytometric analysis of mouse thymocytes. This can be used at less than or equal to 0.5 μg per test. A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. Excitation: 488-561 nm; Emission: 578 nm; Laser: Blue Laser, Green Laser, Yellow-Green Laser. Filtration: 0.2 μm post-manufacturing filtered.

Thymus development depends on a complex series of interactions between thymocytes and the stromal component of the organ. Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis. It is highly homologous to the myelin protein zero and, in thymus-derived epithelial cell lines, is poorly soluble in nonionic detergents, strongly suggesting an association to the cytoskeleton. Its capacity to mediate cell adhesion through a homophilic interaction and its selective regulation by T cell maturation might imply the participation of EVA in the earliest phases of thymus organogenesis. The protein bears a characteristic V-type domain and two potential N-glycosylation sites in the extracellular domain; a putative serine phosphorylation site for casein kinase 2 is also present in the cytoplasmic tail. Two transcript variants encoding the same protein have been found for this gene.
Specifications

Specifications

EVA1
0.2 mg/mL
Flow Cytometry
PE
Mouse
RUO
PBS with 0.09% sodium azide; pH 7.2
O60487, O70255
10205, 14012
Primary
Affinity chromatography
G9P3-1
4°C, store in dark, DO NOT FREEZE!
Monoclonal
Liquid
IgG1 κ
Human, Mouse
Mpzl2
epithelial V-like antigen 1; EVA; Eva1; MPZL2; myelin protein zero like 2; myelin protein zero-like 2; myelin protein zero-like protein 2; UNQ606/PRO1192
Mpzl2
Antibody
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.